Refractec Preparing For February Panel Review Of RF Presbyopia Treatment
This article was originally published in The Gray Sheet
Executive Summary
Refractec expects FDA approval of its CK Blended Vision radio frequency procedure for presbyopia to increase its market opportunity by 18 mil. people